This 2004 case series examines the clinical experiences of eight adult patients who utilized pharmacotherapy for obesity management over a period exceeding 10 years. The medications used included agents such as phentermine and sibutramine. Patients reported sustained weight loss, perceived benefits, and an absence of significant side effects. Notably, there
This 2013 review evaluates the efficacy and safety of phentermine/topiramate extended-release (PHEN/TPM ER) capsules, marketed as Qsymia, for obesity management. Clinical trials demonstrated significant weight loss ranging from 8.1% to 10.9% with mid to high doses, compared to 1.4% to 1.8% with placebo. PHEN/TPM ER also led to reductions in
This 1999 review article evaluates the efficacy, safety, and potential drug interactions of St. John’s wort (Hypericum perforatum) as an alternative treatment for depression. Analyzing nine clinical trials, including four large-scale studies, the review found that St. John’s wort was more effective than placebo and comparable to standard antidepressants in
This 2014 review article discusses the side effects associated with pharmacological treatments for bipolar depression and strategies to manage them. Commonly used medications include mood stabilizers (e.g., lithium, lamotrigine), antipsychotics (e.g., quetiapine, lurasidone), and antidepressants. The article highlights side effects such as weight gain, sedation, gastrointestinal disturbances, and metabolic changes.
This systematic review evaluated 35 randomized controlled trials assessing the efficacy and safety of ketamine in treating Major Depressive Disorder (MDD). Intravenous (IV) ketamine demonstrated significant antidepressant effects in 70% of the studies, while oral and intranasal routes showed limited efficacy. Common adverse effects included nausea, vomiting, dizziness, diplopia, drowsiness,
This 2015 pilot study evaluated the safety and efficacy of dexamphetamine combined with diet and exercise in 14 obese adults over a 6-month period. Participants received up to 30 mg of dexamphetamine twice daily. Twelve completed the treatment, achieving a mean weight loss of 10.6 kg (95% CI: 5.8–15.5, p
This 1962 study by Le Riche and Van Belle evaluated the efficacy and safety of phendimetrazine bitartrate as an appetite suppressant in obese patients. Participants received varying doses of phendimetrazine, and outcomes were assessed in terms of weight loss and side effects. The study found that phendimetrazine effectively suppressed appetite
This 1997 open-label trial assessed the long-term efficacy of misoprostol in 18 patients with chronic refractory constipation. Patients received 600–2400 μg/day of misoprostol. At 4 weeks, 12 patients completed the evaluation, with bowel movement frequency improving from a baseline of 11.25 to 4.8 days (P = 0.0004). Eight patients continued
This 1990 single-blind, randomized clinical trial evaluated the efficacy and skin tolerance of 5% tea-tree oil (TTO) gel compared to 5% benzoyl peroxide (BP) lotion in 124 patients with mild to moderate acne. Both treatments significantly reduced the number of inflamed and non-inflamed lesions, including open and closed comedones. However,
Piracetam, a cyclic derivative of GABA, exhibits neuroprotective, anticonvulsant, and nootropic properties. It modulates neurotransmission across cholinergic and glutamatergic systems, enhances neuroplasticity, and improves microcirculation by reducing erythrocyte adhesion and vasospasm. Clinically, piracetam has demonstrated efficacy in cognitive disorders, dementia, vertigo, cortical myoclonus, dyslexia, and sickle cell anemia. Despite requiring
